| 2-AG | 2-Arachidonoylglycerol |
| AKT | Protein kinase B |
| AML1a | Acute myeloid leukaemia 1a |
| AMP | Adenosine monophosphate |
| AMPK | AMP-activated protein kinase |
| ANGPT2 | Angiopoietin 2 |
| AP-1 | Activator protein 1 |
| APAF1 | Apoptotic peptidase activating factor 1 |
| APC | APC regulator of WNT signalling |
| ASK1 | Apoptosis signal-regulating kinase 1 |
| ATF | Activating transcription factor |
| ATM | Ataxia-telangiectasia mutated |
| ATP | Adenosine triphosphate |
| BAD | BCL2-associated agonist of cell death |
| BAX | BCL2-associated X protein |
| BCL-2 | B-cell lymphoma 2 protein |
| BCL2 | BCL2 apoptosis regulator gene |
| BID | BH3-interacting domain death agonist |
| BiP | Binding immunoglobulin protein |
| BIRC3 | Baculoviral IAP repeat containing 3 |
| BRAF | B-Raf proto-oncogene |
| CASP3 | Caspase 3 |
| CASP8 | Caspase 8 |
| CASP9 | Caspase 9 |
| CB | Cannabinoid receptor |
| CB1R | Cannabinoid receptor type 1 |
| CB2R | Cannabinoid receptor type 2 |
| CBD | Cannabidiol |
| CCND1 | Cyclin D1 |
| CD103 | Cluster of differentiation 103 |
| CD44 | Cluster of differentiation 44 |
| CD8+ | Cluster of differentiation 8-positive |
| Cdc2 | Cell division cycle 2 |
| CDK | Cyclin-dependent kinase |
| CDK1 | Cyclin-dependent kinase 1 |
| CDK2 | Cyclin-dependent kinase 2 |
| CHOP | CCAAT/enhancer-binding protein homologous protein |
| CIK | Cytokine-induced killer |
| CIN | Chromosomal instability |
| CNR1 | Cannabinoid receptor 1 gene |
| COX-2 | Cyclooxygenase-2 |
| CpG | Cytosine-phosphate-guanine dinucleotide |
| CSC | Cancer stem cell |
| CXCL | C-X-C motif chemokine ligand |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| CXCL16 | C-X-C motif chemokine ligand 16 |
| CXCL8 | C-X-C motif chemokine ligand 8; interleukin-8 |
| CXCL9 | C-X-C motif chemokine ligand 9 |
| DCs | Dendritic cells |
| Δ9-THC | Delta-9-tetrahydrocannabinol |
| DNA | Deoxyribonucleic acid |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial-mesenchymal transition |
| ER | Endoplasmic reticulum |
| ERK | Extracellular signal-regulated kinase |
| ERK1/2 | Extracellular signal-regulated kinases 1 and 2 |
| ET-1 | Endothelin-1 |
| FLT1 | Fms-related receptor tyrosine kinase 1 |
| FOXM1 | Forkhead box M1 |
| GBM | Glioblastoma |
| GDF15 | Growth differentiation factor 15 |
| GPCR | G protein-coupled receptor |
| GPR55 | G protein-coupled receptor 55 |
| HCC | Hepatocellular carcinoma |
| HER2 | Human epidermal growth factor receptor 2 |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| HUVEC | Human umbilical vein endothelial cell |
| ICAM-1 | Intercellular adhesion molecule 1 |
| ID-1 | Inhibitor of DNA binding 1 |
| IDO1 | Indoleamine 2,3-dioxygenase 1 |
| IFN-β | Interferon beta |
| IFN-γ | Interferon gamma |
| IL-10 | Interleukin-10 |
| IL-17 | Interleukin-17 |
| IL-1β | Interleukin-1 beta |
| IL-1R | Interleukin-1 receptor |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IRE1 | Inositol-requiring enzyme 1 |
| IRE1α | Inositol-requiring enzyme 1 alpha |
| JAK | Janus kinase |
| JAK-STAT | Janus kinase-signal transducer and activator of transcription |
| JNK | c-Jun N-terminal kinase |
| JNK1/2 | c-Jun N-terminal kinases 1 and 2 |
| KDR | Kinase insert domain receptor |
| KRAS | KRAS proto-oncogene, GTPase |
| LC3-II | Lipidated form II of microtubule-associated protein 1 light chain 3 |
| LPI | Lysophosphatidylinositol |
| MAPK | Mitogen-activated protein kinase |
| MDSC | Myeloid-derived suppressor cell |
| MEK | Mitogen-activated protein kinase/extracellular signal-regulated kinase |
| MGMT | O6-methylguanine-DNA methyltransferase |
| MMP | Matrix metalloproteinase |
| MMP-2 | Matrix metalloproteinase 2 protein |
| MMP-9 | Matrix metalloproteinase 9 protein |
| MMP2 | Matrix metalloproteinase 2 gene |
| MMP9 | Matrix metalloproteinase 9 gene |
| MMPs | Matrix metalloproteinases |
| mTOR | Mechanistic target of rapamycin |
| MYC | MYC proto-oncogene |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NGF | Nerve growth factor |
| NK | Natural killer |
| NKT | Natural killer T |
| NOX4 | NADPH oxidase 4 |
| NOXA | Pro-apoptotic NOXA protein; encoded by PMAIP1 |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| p21 | Cyclin-dependent kinase inhibitor 1A |
| p22phox | Phagocyte oxidase p22 subunit |
| p27 | Cyclin-dependent kinase inhibitor 1B |
| p38 MAPK | p38 mitogen-activated protein kinase |
| p53 | Tumour protein p53 |
| p65 | Nuclear factor κB p65 subunit |
| PAI-1 | Plasminogen activator inhibitor 1 |
| PANC-1 | Human pancreatic carcinoma cell line PANC-1 |
| PDGF-AA | Platelet-derived growth factor AA |
| PERK | Protein kinase R-like endoplasmic reticulum kinase |
| PHB | Prohibitin |
| PI3K | Phosphoinositide 3-kinase |
| PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| PPARγ | Peroxisome proliferator-activated receptor gamma |
| RAF | Rapidly accelerated fibrosarcoma |
| RAS | Rat sarcoma |
| RB | Retinoblastoma tumour suppressor protein |
| RB1 | Retinoblastoma 1 tumour suppressor gene |
| ROS | Reactive oxygen species |
| SCFA | Short-chain fatty acid |
| SRC | SRC proto-oncogene |
| STAT | Signal transducer and activator of transcription |
| STAT1 | Signal transducer and activator of transcription 1 |
| STAT3 | Signal transducer and activator of transcription 3 |
| TBI | Traumatic brain injury |
| TEK | TEK receptor tyrosine kinase |
| THC | Tetrahydrocannabinol |
| TIMP-1 | Tissue inhibitor of metalloproteinases 1 |
| TLR | Toll-like receptor |
| TLR3 | Toll-like receptor 3 |
| TLR4 | Toll-like receptor 4 |
| TME | Tumour microenvironment |
| TMZ | Temozolomide |
| TNBC | Triple-negative breast cancer |
| TNF-α | Tumour necrosis factor alpha |
| TP53 | Tumour protein p53 gene |
| TRP | Transient receptor potential |
| TRPM8 | Transient receptor potential melastatin 8 |
| TRPV | Transient receptor potential vanilloid |
| TRPV1 | Transient receptor potential vanilloid 1 |
| TRPV2 | Transient receptor potential vanilloid 2 |
| TRPV4 | Transient receptor potential vanilloid 4 |
| VEGF | Vascular endothelial growth factor |
| VEGFA | Vascular endothelial growth factor A |
| VHL | Von Hippel-Lindau tumour suppressor |
| WIN 55,212-2 | Synthetic cannabinoid receptor agonist WIN 55,212-2 |